Candler, Toby P and Mahmoud, Osama and Lynn, Richard M and Majbar, Abdalmonen A and Barrett, Timothy G and Shield, Julian PH (2018) Treatment adherence and BMI reduction are key predictors of HbA1c 1 year after diagnosis of childhood type 2 diabetes in the United Kingdom. Pediatric Diabetes, 19 (8). pp. 1393-1399. DOI https://doi.org/10.1111/pedi.12761
Candler, Toby P and Mahmoud, Osama and Lynn, Richard M and Majbar, Abdalmonen A and Barrett, Timothy G and Shield, Julian PH (2018) Treatment adherence and BMI reduction are key predictors of HbA1c 1 year after diagnosis of childhood type 2 diabetes in the United Kingdom. Pediatric Diabetes, 19 (8). pp. 1393-1399. DOI https://doi.org/10.1111/pedi.12761
Candler, Toby P and Mahmoud, Osama and Lynn, Richard M and Majbar, Abdalmonen A and Barrett, Timothy G and Shield, Julian PH (2018) Treatment adherence and BMI reduction are key predictors of HbA1c 1 year after diagnosis of childhood type 2 diabetes in the United Kingdom. Pediatric Diabetes, 19 (8). pp. 1393-1399. DOI https://doi.org/10.1111/pedi.12761
Abstract
Background/Objective Type 2 Diabetes (T2DM) is increasing in childhood especially among females and South-Asians. Our objective was to report outcomes from a national cohort of children and adolescents with T2DM 1 year following diagnosis. Methods Clinician reported, 1-year follow-up of a cohort of children (<17 years) diagnosed with T2DM reported through the British Paediatric Surveillance Unit (BPSU) (April 2015-April 2016). Results One hundred (94%) of 106 baseline cases were available for review. Of these, five were lost to follow up and one had a revised diagnosis. Mean age at follow up was 15.3 years. Median BMI standard deviation scores (SDS) was 2.81 with a decrease of 0.13 SDS over a year. HbA1c <48 mmol/mol (UK target) was achieved in 38.8%. logHbA1c was predicted by clinician reported compliance and attendance concerns (β = 0.12, P = <0.0001) and change in body mass index (BMI) SDS at 1-year (β = 0.13, P=0.007). In over 50%, clinicians reported issues with compliance and attendance. Mean clinic attendance was 75%. Metformin was the most frequently used treatment at baseline (77%) and follow-up (87%). Microalbuminuria prevalence at 1-year was 16.4% compared to 4.2% at baseline and was associated with a higher HbA1c compared to those without microalbuminuria (60 vs 49 mmol/mol, P = 0.03). Conclusions Adherence to treatment and a reduction in BMI appear key to better outcomes a year after T2DM diagnosis. Retention and clinic attendance are concerning. The prevalence of microalbuminuria has increased 4-fold in the year following diagnosis and was associated with higher HbA1c.
Item Type: | Article |
---|---|
Uncontrolled Keywords: | Adolescent; Age of Onset; Blood Glucose; Body Mass Index; Child; Diabetes Mellitus, Type 2; Female; Follow-Up Studies; Glycated Hemoglobin A; Humans; Male; Population Surveillance; Prognosis; Time Factors; Treatment Adherence and Compliance; United Kingdom; Weight Loss; Young Adult |
Divisions: | Faculty of Science and Health Faculty of Science and Health > Mathematics, Statistics and Actuarial Science, School of |
SWORD Depositor: | Unnamed user with email elements@essex.ac.uk |
Depositing User: | Unnamed user with email elements@essex.ac.uk |
Date Deposited: | 05 Feb 2023 18:27 |
Last Modified: | 30 Oct 2024 16:18 |
URI: | http://repository.essex.ac.uk/id/eprint/32203 |
Available files
Filename: Treatment adherence and BMI reduction are key predictors of HbA1c 1 year after diagnosis of childhoo.pdf
Licence: Creative Commons: Attribution-Noncommercial 4.0